Načítá se...
Thrombus Formation in Left Atrium on Dabigatran Therapy
Dabigatran is a direct thrombin inhibitor, approved in the United States for stroke prevention in nonvalvular atrial fibrillation and prevention and treatment of thromboembolism. It has been also used in patients with documented left atrial thrombus, where treatment with dabigatran effectively led t...
Uloženo v:
| Vydáno v: | Case Rep Cardiol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi Publishing Corporation
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4352418/ https://ncbi.nlm.nih.gov/pubmed/25793127 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/518982 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|